Compounds > dipyridamole

dipyridamole and atazanavir sulfate

dipyridamole has been researched along with atazanavir sulfate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Azoulay, S; Burger, A; Créminon, C; Duval, D; Garraffo, R; Grassi, J; Lavrut, T; Nevers, MC; Roucairol, C1
Ma, C; Wang, J1
Huang, YY; Li, Z; Lin, Y; Liu, R; Luo, HB; Wang, X; Zhan, CG1

Other Studies

3 other study(ies) available for dipyridamole and atazanavir sulfate

ArticleYear
Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cells.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Animals; Antibodies; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cattle; Cells, Cultured; Dipyridamole; Dose-Response Relationship, Drug; HIV Protease Inhibitors; Humans; Immunoassay; Oligopeptides; Phosphodiesterase Inhibitors; Pyridines; Rabbits; Sensitivity and Specificity; T-Lymphocytes

2007
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-23, Volume: 118, Issue:8

    Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Pharmaceutical Preparations; Protease Inhibitors; Quinolines; SARS-CoV-2; Sulfides; Tetrazoles

2021
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-23, Volume: 118, Issue:8

    Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Protease Inhibitors; Quinolines; Reproducibility of Results; SARS-CoV-2; Sulfides; Tetrazoles

2021